Patents by Inventor Anne E. Anderson

Anne E. Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9525676
    Abstract: A computer program product for processing a message is provided. The computer program product comprises a computer readable storage medium having program instructions embodied therewith. The program instructions readable by a processing circuit cause the processing circuit to perform a method. The method validates a security token for a user. The method allows the user to compose a message. Based on the security token, the method verifies that the user is authorized to send the message to an intended recipient of the message and that a security level of the message is at or below a security level of the user.
    Type: Grant
    Filed: May 28, 2014
    Date of Patent: December 20, 2016
    Assignee: Raytheon Company
    Inventors: Anne E. Anderson, Matthew R. Ashoff, Charles B. Bradley, II
  • Publication number: 20150052597
    Abstract: A computer program product for processing a message is provided. The computer program product comprises a computer readable storage medium having program instructions embodied therewith. The program instructions readable by a processing circuit cause the processing circuit to perform a method. The method validates a security token for a user. The method allows the user to compose a message. Based on the security token, the method verifies that the user is authorized to send the message to an intended recipient of the message and that a security level of the message is at or below a security level of the user.
    Type: Application
    Filed: May 28, 2014
    Publication date: February 19, 2015
    Applicant: Raytheon Company
    Inventors: Anne E. Anderson, Matthew R. Ashoff, Charles B. Bradley, II
  • Publication number: 20020058699
    Abstract: Excessive brain neuronal excitability, associated with a seizure disorder, can be correlated with increased mitogen-activated protein kinase (MAPK) activity in neurons. Such excessive excitability can be ameliorated by administering an effective amount of a compound, such as a MAPK phosphorylation or kinase activity inhibitor, that reduces the amount of MAPK activity in neurons of an individual suffering from a seizure disorder. Compounds that inhibit phosphorylation or kinase activity of upstream activators or downstream targets of the MAPK cascade also are useful in this context.
    Type: Application
    Filed: June 29, 2001
    Publication date: May 16, 2002
    Inventors: J. David Sweatt, Anne E. Anderson